Aeolus Pharmaceuticals, Inc.
Aeolus Pharmaceuticals, Inc. (AOLS) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
aols · pe ratio · data through Sep 30, 2016
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Aeolus Pharmaceuticals, Inc. (AOLS) measures how much investors pay for each dollar of the company's trailing earnings. AOLS's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.02.
Source: FMP · /ratios-ttm · /analyst-estimates · 2016-09-30
PE Ratio History
1997 – 2016 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Aeolus Pharmaceuticals, Inc.You AOLS | $0M | N/A | — | -$0.02 |
 CannTrust Holdings Inc. CNTTQ | $0M | N/A | — | -$0.14 |
 DrazCanna, Inc. DZCA | $0M | N/A | — | -$0.01 |
 Halo Collective Inc. HCANF | $0M | N/A | — | -$10.55 |
 Lowell Farms Inc. LOWLF | $0M | N/A | — | -$2.71 |
 MPX International Corporation MPXOF | $0M | N/A | — | -$0.19 |
 Cannabis Strategic Ventures NUGS | $0M | N/A | — | -$0.03 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2016-09-30Latest FY2016 | — | $-0.02 | — | |
2015-09-30 FY2015 | — | $-0.02 | — | |
2014-09-30 FY2014 | — | $-0.00 | — | |
2013-09-30 FY2013 | — | $-0.03 | — | |
2012-09-30 FY2012 | 13.42x | $0.03 | -83.9% | |
2011-09-30 FY2011 | 83.54x | $0.01 | — | |
2010-09-30 FY2010 | — | $-0.53 | — | |
2009-09-30 FY2009 | — | $-0.07 | — | |
2008-09-30 FY2008 | — | $-0.09 | — | |
2007-09-30 FY2007 | — | $-0.10 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Aeolus Pharmaceuticals, Inc. (AOLS) measures how much investors pay for each dollar of the company's trailing earnings. AOLS's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.02.
Frequently asked questions
AOLS pe ratio · 6 questionsAOLS's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$0.02. Data sourced from Financial Modeling Prep via AOLS's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Aeolus Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09